Tweets
Maeve Gamble @MaeveGamble ( View Tweet )
Maeve Gamble @MaeveGamble ( View Tweet )
The C-AxSpand study, Certolizumab-treated nr-axSpA pts with shorter symptom duration (< 5 vs ≥ 5 years) showed greater improvements across signs and symptoms of disease and in quality of life. Kay J et al #ACR19 @RheumNow
Dr. Antoni Chan @synovialjoints ( View Tweet )
Dr Irwin Lim @_connectedcare ( View Tweet )
Dr. Antoni Chan @synovialjoints ( View Tweet )


